FDA Moves To Implement New GMP Policies

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-11-02-2004, Volume 28, Issue 11

Phase II of FDA's GMP modernization plan may involve revising regulations to fit new policies and inspection and review programs.

Related Content:

Regulatory/GMP ComplianceProcess ValidationQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-11-02-2004
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products